ImmunoGen
IMGN
$31.23
Share price
0.00%
Change (1 day)
622.92%
Change (1 year)
Categories
ImmunoGen (IMGN) - Net assets
Net assets on the balance sheet as of September 2023 : $0.56 B
According to ImmunoGen
's latest financial reports the company has $0.56 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
ImmunoGen - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.15 B | -52.14% |
| 2021-12-31 | $0.32 B | 263.5% |
| 2020-12-31 | $89.57 M | -217.67% |
| 2019-12-31 | $-76.13 M | -793.78% |
| 2018-12-31 | $10.97 M | -161.31% |
| 2017-12-31 | $-17.9 M | |
| 2016-06-30 | $-82.31 M | -334.46% |
| 2015-06-30 | $35.1 M | -53.63% |
| 2014-06-30 | $75.69 M | -37.87% |
| 2013-06-30 | $0.12 B | 45.25% |
| 2012-06-30 | $83.89 M | -40.07% |
| 2011-06-30 | $0.13 B | 37.16% |
| 2010-06-30 | $0.10 B | 52.64% |
| 2009-06-30 | $66.85 M | 20.9% |
| 2008-06-30 | $55.29 M | -5.31% |
| 2007-06-30 | $58.4 M | -19.28% |
| 2006-06-30 | $72.35 M | -16.69% |
| 2005-06-30 | $86.84 M | -10.6% |
| 2004-06-30 | $97.13 M | -5.4% |
| 2003-06-30 | $0.10 B | -23.5% |
| 2002-06-30 | $0.13 B | -5.78% |
| 2001-06-30 | $0.14 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 12,146.17% | 🇺🇸 USA |
 Novartis NVS | $39.75 B | 6,979.11% | 🇨🇭 Switzerland |
 Pfizer PFE | $89.28 B | 15,798.97% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | 1,834.43% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 1,009.69% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 14,537.46% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $29.48 B | 5,150.22% | 🇺🇸 USA |
 Seagen
SGEN | $2.55 B | 354.14% | 🇺🇸 USA |